The 20 Best Sepsis Doctors near Rosedale, MD

Dr. Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections, and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 20 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices funded by the Agency for Healthcare Research and Quality, and approaches to improve how antibiotics are given via a randomized trial to compare intravenous and oral therapy for Gram negative bacteremia funded by PCORI. She is the PI of the Johns Hopkins Prevention Epicenter, a Centers for Disease Control and Prevention-funded program that integrates antimicrobial stewardship, healthcare epidemiology, human factors engineering, data science, and implementation science to address knowledge gaps and develop strategies to optimize patient safety by preventing transmission of pathogens and improving antibiotic use in diverse healthcare settings and patient populations. She is a past voting member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her master of science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center. Dr. Cosgrove is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Pneumonia, and Pseudomonas Stutzeri Infections.

Karen Carroll is an Infectious Disease provider in Baltimore, Maryland. Dr. Carroll is rated as a Distinguished provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Methicillin-Resistant Staphylococcus Aureus (MRSA), Sepsis, Pneumonia, and Meningitis.

Dr. Trevor Crowell is an adjunct assistant professor at the Johns Hopkins University School of Medicine. His areas of clinical expertise include HIV/AIDS, sexually transmitted infections, and other infectious diseases. Dr. Crowell earned his M.D. from the University of Southern California Keck School of Medicine and his Ph.D. in clinical investigation from the Johns Hopkins Bloomberg School of Public Health. He completed his residency at Case Western Reserve University/University Hospitals Case Medical Center and completed a fellowship in infectious diseases at Johns Hopkins. In addition to serving as a staff physician at Bayview Medical Center, Dr. Crowell is an Associate Director at the U.S. Military HIV Research Program, Walter Reed Army Institute of Research. He is also an assistant professor of medicine at the Uniformed Services University of the Health Sciences. Dr. Crowell is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Gonorrhea, Chlamydia, and Sepsis.

Dr. Thomas Quinn is professor of medicine and pathology in the Johns Hopkins School of Medicine and professor of international health, epidemiology, and molecular microbiology and immunology in The Johns Hopkins School of Public Health, and professor of nursing in the Johns Hopkins School of Nursing. In 2006 he was appointed founding Director of the Johns Hopkins University Center for Global Health. He serves as advisor/consultant on HIV and STDs to the World Health Organization, Office of the Global AIDS Coordinator (PEPFAR), UNAIDS, and the FDA. He serves as Associate Director for International Research at the National Institute of Allergy and Infectious Diseases. He is a member of the Institute of Medicine of the National Academy of Sciences, and is a fellow of the American Association for the Advancement of Science. He is a fellow of the Infectious Diseases Society of America and a member of the American Association of Physicians. He is an author of over 900 publications on HIV, STDs, and infectious diseases, and serves on multiple editorial boards. Among his professional activities, Dr. Quinn is an alternate member of the Technical Panel of the Global Fund to Fight AIDS, Malaria, and Tuberculosis and has been on Advisor/Consultant on HIV and STDs to the World Health Organization, UNAIDS, and the U.S. Food and Drug Administration. In October 2004 he received membership in the Institute of Medicine. Dr. Quinn is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Genital Herpes, Chlamydia, and Human Papillomavirus Infection.

Dr. Richard Moore is recognized for mentorship of medical students, residents, fellows, and junior faculty in HIV/AIDS Research. Winner of the David M. Levine Mentorship Awards in the General Internal Medicine Department, he is an expert in pharmacoepidemiology, clinical epidemiology, and health services research. Now serving as the Director of the Moore Clinic for HIV Care, which began in 1984, he has influenced the careers of young scholars not only in General Internal Medicine, but also in the Infectious Disease Division. His colleagues and mentees praise him for his accessibility, his patience, his scientific candor, his instinct for compelling research, his insight, and his abilities as a teacher and editor. Dr. Moore has authored 129 original manuscripts, 24 chapters, reviews and letters. For his medical degree he attended Vanderbilt University School of Medicine where he also completed his Internship and Residency in the Department of Medicine. A fellowship, completed at Johns Hopkins University, Department of Medicine, Division of Internal Medicine, was followed by a Masters of Health Sciences at the Johns Hopkins University, Bloomberg School of Public Health, Department of Epidemiology. Dr. Moore is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Sepsis, Hepatitis C, Hepatitis, and Gastrostomy.

Dr. Joel Blankson is an associate professor of medicine at the Johns Hopkins University School of Medicine. He also holds an appointment in molecular and comparative pathobiology. His areas of clinical expertise include HIV pathogenesis and infectious disease. Dr. Blankson earned his M.D. from Cornell University Medical College and his Ph.D. from Rockefeller University. He completed his residency and a fellowship in infectious disease at Johns Hopkins. His research interests include the natural control of HIV-1 infection. Dr. Blankson is rated as an Advanced provider by MediFind in the treatment of Sepsis. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.

Dr. Kelly Gebo is a graduate of The Johns Hopkins University School of Medicine. She also earned an MPH in Epidemiology from The Johns Hopkins Bloomberg School of Public Health. She completed residency training in Internal Medicine at The Johns Hopkins Hospital followed by an infectious diseases fellowship and two additional years of fellowship training as a Robert Wood Johnson Clinical Scholar, also at Hopkins. Her clinical and research interests include clinical outcomes and healthcare utilization research within infectious diseases. She was Director of the JHU Public Health Studies Program between the Krieger School for Arts and Sciences and the Bloomberg School for Public Health, was an American Council of Education Fellow (hosted at the University of Pennsylvania) and was the inaugural Vice Provost for Education at Johns Hopkins. She was on sabbatical at Stanford University School of Medicine 2019-20 and served as the Chief Medical and Scientific Officer for the All of Us Research Program 2018-2020. She currently serves as the director of the Johns Hopkins Clinical Research Scholars Program and is Deputy Director of the Johns Hopkins Institute for Clinical and Translational Research. She has mentored undergraduate, public health and medical students, trainees, and junior faculty on infectious diseases and health services projects. She has authored or co-authored numerous chapters and over 250 papers. She is a member of the American Society of Clinical Investigation and has been awarded the David Levine Prize for mentoring at Johns Hopkins. LinkedIn https://www.linkedin.com/in/kelly-gebo-13377811/. Dr. Gebo is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Myelitis, AIDS Dysmorphic Syndrome, and AIDS Dementia Complex.

Dr. Yukari Manabe is a Professor in the Division of Infectious Diseases in the Department of Medicine with secondary appointments in the Bloomberg School of Public Health Department of International Health and the Department of Microbiology and Molecular Immunology. Dr. Manabe began her career working on the basic science aspects of tuberculosis (TB) immunopathogenesis in comparative animal models of infection, particularly latency, reactivation, and immune reconstitution inflammatory syndrome (IRIS) in the rabbit model within the Johns Hopkins Center for Tuberculosis Research. In 2007, she was seconded to the Infectious Diseases Institute (IDI) at Makerere College of Health Sciences as the Associate Medical Laboratory Director of the College of American Pathologists certified Makerere University-Johns Hopkins University Clinical Core Lab to study antiretroviral associated TB and IRIS. She then became the Head of Research at the IDI in 2008 until 2012 where she built research capacity and infrastructure to train Ugandan investigators. Since returning to Hopkins, she has become the PI of the Johns Hopkins POC STD Center (U54 funded through NIH) which is part of the newly formed Johns Hopkins Center for Innovative Diagnostics for Infectious Diseases. The Center develops new diagnostics, funds development for point-of-care diagnostics, evaluates (validation and verification) new technology, and performs pre-clinical studies to accelerate the development of infectious disease assays (STIs, TB, acute febrile illness, HIV, syphilis, viral hepatitis). Dr. Manabe is particularly interested in rapid, point-of-care infectious disease diagnostics suitable for the resource-limited settings particularly in sub-Saharan Africa (SSA). Her research has focused on accuracy testing of various rapid, point-of-care diagnostics for HIV and related infectious diseases of clinical importance in SSA. Studies have ranged from evaluations of performance accuracy through clinical implementation science studies on the patient-centered outcomes and impactful use of new rapid diagnostics. Dr. Manabe obtained her undergraduate degree from Yale University and her M.D. from Columbia University College of Physicians and Surgeons. After completing both her residency in Internal Medicine and fellowship in Infectious Diseases at Johns Hopkins Hospital, she joined the faculty in 1999. Dr. Manabe is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are HIV/AIDS, Cryptococcosis, Gonorrhea, Meningitis, and Tissue Biopsy.

John Baddley is an Infectious Disease provider in Baltimore, Maryland. Dr. Baddley is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Cryptococcosis, Shingles, Sepsis, and Febrile Neutropenia.

Dr. Aaron M. Milstone is a professor of pediatrics at the Johns Hopkins University School of Medicine. He holds a joint appointments in Epidemiology and Health Policy and Management at the Bloomberg School of Public Health. A pediatric epidemiologist, Dr. Milstone specializes in treating infectious diseases in children. He serves as an associate hospital epidemiologist at The Johns Hopkins Hospital and the pediatric lead for infection prevention for the Johns Hopkins Health System. Dr. Milstone earned his medical degree from Yale University School of Medicine. He completed both a pediatrics residency and a research fellowship in pediatric infectious diseases at Children's Hospital of Philadelphia. He also completed a pediatric infectious diseases fellowship at Johns Hopkins. He holds a M.H.S. (Graduate Training Program in Clinical Investigation) from the Johns Hopkins Bloomberg School of Public Health and Johns Hopkins University School of Medicine. Dr. Milstone joined the Johns Hopkins faculty in 2007. His research interests focus on antibiotic resistance and prevention of healthcare-associated infections. He had led numerous clinical trials including the Pediatric SCRUB Trial and TREAT PARENTS Trial testing strategies to prevent organism transmission and healthcare-associated infections. He is principal investigator of the BrighT STAR Collaborative, guiding hospitals nationwide to reduce over-testing as a strategy to reduce antibiotic use and resistance. Dr. Milstone is a fellow of the American Academy of Pediatrics, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society for Healthcare Epidemiology of America. His many other professional honors include the Pediatric Infectious Diseases Society’s 2014 Young Investigator Award, the inaugural 2013 Caroline B. Hall Clinical Innovation Award, and the Society for Healthcare Epidemiology of America 2018 Mentor Scholar Award, and 2023 Johns Hopkins Medicine Armstrong Award for Excellence in Quality & Safety. Dr. Milstone is rated as a Distinguished provider by MediFind in the treatment of Sepsis. His top areas of expertise are Sepsis, Methicillin-Resistant Staphylococcus Aureus (MRSA), Severe Acute Respiratory Syndrome (SARS), and Neonatal Sepsis.

Dr. Karaba is an Assistant Professor of Medicine at the Johns Hopkins University School of Medicine. She is an infectious diseases physician and the Associate Director of the Antimicrobial Stewardship Program and an Associate Hospital Epidemiologist at Johns Hopkins Bayview Medical Center. Dr. Karaba’s research interests include the epidemiology and treatment multidrug-resistant bacterial infections and the prevention of hospital-acquired infections. Dr. Karaba is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Sepsis, COVID-19, Severe Acute Respiratory Syndrome (SARS), and Pneumonia.

Dr. Peter M. Abadir is a geriatrician and translational researcher at Johns Hopkins University. He serves as the Principal Investigator of the Johns Hopkins Artificial Intelligence and Technology Collaboratory for Aging Research, where he leads interdisciplinary initiatives to advance innovations in aging and resilience science. His clinical focus includes frailty, cognitive decline, and age-related conditions, while his translational research bridges molecular biology, bioengineering, and geriatrics. Dr. Abadir is an Associate Professor in the Division of Geriatric Medicine and Gerontology at the Johns Hopkins School of Medicine and holds a joint appointment in Electrical and Computer Engineering at the Whiting School of Engineering. He also directs the Molecular Measurement Core of the Johns Hopkins Older Americans Independence Center and co-directs the Clinical Translation and Validation Core for the Artificial Intelligence and Technology Collaboratory. He currently serves as Chair of the MD Admissions Committee for the Johns Hopkins School of Medicine, overseeing the selection of the next generation of leaders in medicine. Additionally, Dr. Abadir is the Deputy Editor of the Journal of the American Geriatrics Society and serves on several other journal editorial boards. Among his research contributions, Dr. Abadir was among the first to describe the presence of a mitochondrial angiotensin system, providing new insights into cellular energy metabolism and aging. His pioneering work has also focused on biomarkers for frailty and cognitive decline, including circulating mitochondrial DNA and inflammation-related pathways. Notably, his research on the use tof topical angiotensin system blockers has introduced novel approaches to wound healing in aging populations. Dr. Abadir is a recipient of the Nathan Shock Scholar in Aging Award and the Frederick L. Brancati Excellence in Mentoring Award. Additionally, he has received the Johns Hopkins Institute for Excellence in Education Leadership and Mentorship Award and was inducted into the Johns Hopkins Distinguished Teaching Society, reflecting his outstanding contributions to mentorship and education. Dr. Abadir co-founded the Johns Hopkins Gerotech Incubator Program, which integrates medicine, engineering, and technology to develop solutions that enhance the health and independence of older adults. LinkedInhttps://www.linkedin.com/in/peter-abadir-87401715/. Dr. Abadir is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Dementia, Alzheimer's Disease, Vasoconstriction, and Muscle Atrophy.

Morgan Katz, M.D., MHS, is an Associate Professor of medicine at The Johns Hopkins University School of Medicine and the Director of Antimicrobial Stewardship at Johns Hopkins Bayview Hospital. Her area of clinical expertise is infectious diseases. Her research interests lie in infection control and antibiotic stewardship in long-term care facilities. She has focused her career on designing feasible interventions to reduce antimicrobial resistance and transmission of infection in the long-term care setting. She served as a member of the White House Nursing Home Commission to guide the Centers for Medicare and Medicaid in their response to Coronavirus in long-term care facilities, and has published widely on infection prevention and antibiotic stewardship in long-term care. Dr. Katz is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Lemierre Syndrome, Severe Acute Respiratory Syndrome (SARS), COVID-19, Osteomyelitis, and Thrombectomy.

William F. Wright, D.O., M.P.H, Assistant Professor of Medicine, completed medical training residency in internal medicine and adult infectious diseases fellowship at Pennylvania State University Medical School. He pursued further training in Clinical Pathology/Medical Microbiology at Yale University School of Medicine, New Haven (2009) and completed his Master in Public Health (2007) at Drexel University School of Public Health, Philadelphia. His research interests include fever of unknown origin (FUO), antimicrobial resistance and therapeutic discoveries, molecular mechanisms of resistance, and the impact of diagnostic clinical microbiology on the practice of infectious diseases. He currently serves as clinical director for the inpatient infectious diseases consult services and services for the management of outpatient parenteral antimicrobial therapy (OPAT) at Johns Hopkins Bayview Medical Center. His outpatient clinical practice focuses on general infectious diseases, infections in burn patients, infections in immunocompromised patients, and travel-related infections. He primarily sees patients at Johns Hopkins Greenspring Station, Johns Hopkins Bayview Outpatient offices, and also attends on the inpatient infectious disease consult service at the Johns Hopkins Bayview Medical Center and Johns Hopkins Hospital. Dr. Wright is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Osteomyelitis, Osteomyelitis in Children, Meningitis, and Endocarditis.

1988-1992, Assistant Professor, Department of Pharmacology, Semmelweis Medical University, Budapest, Hungary. 1992-1996, Instructor, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD. 2001-2014, Assistant Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2012-2014, Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Associate Professor, Division of Geriatric Medicine and Gerontology, Johns Hopkins University School of Medicine, Baltimore, MD. 2014-present, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD. Dr. Yasar is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Normal Pressure Hydrocephalus, Congenital Cardiovascular Shunt, Dementia, and Alzheimer's Disease.

Dr. Noreen Hynes has over 35 years of medical and public health experience in both international and domestic settings. Her career has encompassed basic and applied research, epidemiology, public health, clinical medicine, and the regulatory aspects of medical countermeasures for emerging and infectious diseases and high-consequence pathogens. Dr. Hynes has been affiliated with The Johns Hopkins Medical Institutions and the Schools of Medicine and Public Health University since 1997. She is currently an Associate Professor of Medicine (part-time) in the School of Medicine, Division of Infectious Diseases, and is jointly appointed in the School of Public Health in the Department of International Health. Since 2009, Dr. Hynes has served as the director of the Geographic Medicine Center in the Division of Infectious Diseases in the Johns Hopkins School of Medicine, as the Medical Director of the Johns Hopkins Tropical & Travel Medicine Service, and as the Baltimore Site Director for the CDC-sponsored GeoSentinel Surveillance System. Dr. Hynes serves as the Director of Research and the Associate Medical Director of the Johns Hopkins Hospital BioContainment Unit. She also serves as the co-director of the Infectious Disease concentration in the Johns Hopkins Master of Public Health degree program. Dr. Hynes' research interests focus on infectious diseases at the clinical-public health interface in resource-constrained settings in both tropical and temperate regions. Her research focuses on tropical diseases, including those that or zoonoses or high-consequence pathogens. Her research focuses on these pathogens including examining deliberate and naturally-occurring exposures/outcomes, the epidemiology and control of emerging infectious diseases, and collaboration on vaccine clinical trials conducted by the Center for Immunization Research at the Johns Hopkins Bloomberg School of Public Health. Dr. Hynes is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Viral Hemorrhagic Fever, Ebola Virus Disease, Dengue Fever, and COVID-19.

Dr. Oluwaseun O. Falade-Nwulia is an assistant professor of medicine at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include infectious disease. Dr. Falade-Nwulia earned her M.B.B.S. from the University of Ibadan Medical School College of Medicine. She completed her residency at Johns Hopkins Bayview Medical Center. She performed fellowships in infectious diseases at Johns Hopkins and a fellowship in critical care medicine at the National Institutes of Health. Dr. Falade is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Hepatitis C, Hepatitis, HIV/AIDS, and Sepsis.

Dr. Danelle Cayea is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. She is a specialist in geriatric medicine. Her clinical interests include the primary care of older adults with chronic illness and the care of hospitalized older adults. She serves as the director of the Daniel and Jeannette Hendin Schapiro Geriatric Medical Education Center, as the vice chair for education for the Department of Medicine, and as the Director of the Medicine Core Clerkship Program. Her research focuses on developing and evaluating curricula used to teach medical trainees about elder care. She has published a number of scholarly articles and book chapters on this topic and has been recognized for her teaching excellence. Dr. Cayea holds an M.S. in medical education from the University of Pittsburgh School of Medicine. She earned her medical degree at the University of Rochester School of Medicine and Dentistry. She completed internal medicine residencies at both Montefiore University Hospital and Children's Hospital of Pittsburgh, as well as a geriatric medicine fellowship at University of Pittsburgh Medical Center. Dr. Cayea is rated as an Experienced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Chondroma, Chondroblastoma, Mitral Stenosis, and Osteochondroma.

William Norbury, M.D., F.R.C.S. (Plast), is an associate professor of plastic surgery (PAR) in the Johns Hopkins Department of Plastic and Reconstructive Surgery, and part of the Johns Hopkins Adult Burn Center. His areas of clinical expertise include surgical reconstruction of severe burns, burn reconstruction, and laser attenuation of scar tissue. He received a Bachelor of Medicine degree from St. Bartholomew’s and the Royal London Hospital Medical College. He obtained a Membership of the Royal College of Surgeons postgraduate diploma at the Royal College of Physicians and Surgeons of Glasgow in 2003, and completed a Royal College of Surgeons fellowship in plastic surgery in 2012. In addition to performing his residency in plastic surgery, Dr. Norbury completed a fellowship in the therapeutic use of lasers in the United Kingdom, as well as fellowships in reconstructive burn surgery and surgical critical care at the University of Texas Medical Branch and Shriners Children’s Texas. He also completed a three-year fellowship in burn care research — focused on attenuation of the hypermetabolic response following severe burns — at Shriners Children’s Texas. Dr. Norbury’s research activities focus on nutrition in burn care, hypermetabolism, wound healing, sepsis, burn reconstruction and laser treatment of hypertrophic scarring. He has authored more than 30 peer-reviewed publications and presented his work at numerous national and international meetings. He is a member of the American Burn Association, the British Burn Association, the International Society for Burn Injuries, the American Society for Laser Medicine and Surgery, and the Royal College of Physicians and Surgeons of Glasgow. Dr. Norbury is rated as an Experienced provider by MediFind in the treatment of Sepsis. His top areas of expertise are Keloids, Syndactyly Type 3, Juvenile Angiofibroma, and Buerger Disease.

Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is rated as an Advanced provider by MediFind in the treatment of Sepsis. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.